SARS-CoV Spike anticorps (AA 19-35)
Aperçu rapide pour SARS-CoV Spike anticorps (AA 19-35) (ABIN199988)
Antigène
Voir toutes SARS-CoV Spike (SARS-CoV S) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 19-35
-
Specificité
- The antibody was developed using a synthetic peptide from the putative SARS Spike glycoprotein (Genbank accession no. NP_828851) corresponding to amino acids 19-35.
-
Purification
- Protein G purified
-
Immunogène
-
Type of Immunogen: Native protein
-
-
-
-
Indications d'application
- Approved: WB (1 - 3 μg/mL)
-
Commentaires
-
Target Species of Antibody: SARS Coronavirus
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))
-
Autre désignation
- SARS-CoV Spike
-
Classe de substances
- Viral Protein
-
Sujet
-
Name/Gene ID: S
Family: Virion Structure
Synonyms: S, E2, S E2 glycoprotein, E2 glycoprotein precursor -
ID gène
- 1489668
Antigène
-